Spitalul Clinic Judetean De Urgenta Sf. Spiridon Iasi
- Address
- lock Available on a paid plan
Spitalul Clinic Judetean De Urgenta Sf. Spiridon Iasi - Autoimmune and Dermatological Research
Spitalul Clinic Judetean De Urgenta Sf. Spiridon Iasi is actively engaged in advanced clinical research focused on autoimmune disorders and their innovative therapeutic management. The center demonstrates particular expertise in evaluating novel biologic therapies for complex immunological conditions affecting multiple organ systems.
- Autoimmune dermatological conditions including Bullous Pemphigoid
- Thyroid Eye Disease and endocrine-related autoimmune disorders
- Phase 2/3 therapeutic trials using subcutaneous biologics
The research center's portfolio emphasizes sustained remission outcomes and patient-centered endpoints in autoimmune disease management. Their involvement in trials evaluating efgartigimod PH20 SC delivery systems reflects a commitment to advancing more convenient administration methods for patients requiring long-term immunomodulatory therapy, particularly in rare and challenging conditions such as bullous pemphigoid and thyroid eye disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Janssen Cilag International2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Spitalul Clinic Judetean De Urgenta Sf. Spiridon Iasi
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| An 18-month low-interventional prospective, multicentre study to assess joint outcomes in patients with haemophilia A or B on prophylaxis with efmoroctocog alfa or eftrenonacog alfa | Swedish Orphan Biovitrum AB (publ) | Phase III | Not Yet Recruiting | Jul 2023 | Dec 2023 |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Efgartigimod Alfa | 2 | Unknown | 2022-05-10 | 2024-10-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.